在治疗成本异质的临床试验中实施非均等随机化
本文研究在统计效率约束下最小化研究成本的最优分配设计,针对平行组临床试验比较多种研究性治疗与对照。理论表明均等分配设计可能次优,非均等分配设计可在相同预算下提供更高统计功效或在相同功效水平下产生更小成本。本文还展示了如何通过限制性随机化程序在实践中实施最优分配,以及如何使用基于总体或基于随机化的方法进行统计推断。
要点
- 均等分配设计可能次优,非均等分配设计可在相同预算下提供更高统计功效或在相同功效水平下降低研究成本。
- 最优分配可通过限制性随机化程序在实践中实施,并可使用基于总体或基于随机化的方法进行统计推断。
- 目标分配、随机化程序与数据分析统计方法的选择是确保临床试验结果有效、有功效且稳健的关键组成部分。
核心结论
- 非均等随机化设计具有成本效益,并可在实践中成功实施。
- 目标分配、随机化程序和数据分析统计方法的选择是确保有效、有功效且稳健的临床试验结果的关键组成部分。
研究设计与样本
- 平行组临床试验,比较多种研究性治疗与对照,研究在统计效率约束下最小化研究成本的最优分配设计。
主要发现
- 均等分配设计可能次优。
- 非均等分配设计可在相同预算下提供更高统计功效。
- 非均等分配设计可在相同功效水平下产生更小成本。
临床怎么用
- 最优分配可通过限制性随机化程序在实践中实施。
- 可使用基于总体或基于随机化的方法进行统计推断。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Equal randomization has been a popular choice in clinical trial practice. However, in trials with heterogeneous variances and/or variable treatment costs, as well as in settings where maximization of every trial participant's benefit is an important design consideration, optimal allocation proportions may be unequal across study treatment arms. In this paper, we investigate optimal allocation designs minimizing study cost under statistical efficiency constraints for parallel group clinical trials comparing several investigational treatments against the control. We show theoretically that equal allocation designs may be suboptimal, and unequal allocation designs can provide higher statistical power for the same budget or result in a smaller cost for the same level of power. We also show how optimal allocation can be implemented in practice by means of restricted randomization procedures and how to perform statistical inference following these procedures, using invoked population-based or randomization-based approaches. Our results provide further support to some previous findings in the literature that unequal randomization designs can be cost efficient and can be successfully implemented in practice. We conclude that the choice of the target allocation, the randomization procedure, and the statistical methodology for data analysis is an essential component in ensuring valid, powerful, and robust clinical trial results.
引用
- Sverdlov O, Ryeznik Y. Implementing unequal randomization in clinical trials with heterogeneous treatment costs. Stat Med. 2019. PMID: 31049999. doi:10.1002/sim.8160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。